Publication:
Susceptibility of bacterial isolates from Turkey - A report from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program

Simple item page
dc.contributor.authorKORTEN, VOLKAN
dc.contributor.authorsEraksoy, H.; Basustaoglu, A.; Korten, V.; Kurt, H.; Ozturk, R.; Ulusoy, S.; Yaman, A.; Yuce, A.; Zarakolu, P.
dc.date.accessioned2022-03-12T17:33:20Z
dc.date.available2022-03-12T17:33:20Z
dc.date.issued2007
dc.description.abstractThe study monitored the susceptibility of nosocomial pathogens to meropenem and comparator antimicrobial agents isolated as part of the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program from Turkish university hospitals. In terms of minimum inhibitory concentration 90% (MIC90) values, meropenem was two- and eight-fold more active than imipenem against Escherichia coli and Klebsiella pneumoniae, respectively. 40.5% of K. pneumoniae, 23.1% of Klebsiella oxytoca and 15.3% of E. coli isolates were extended-spectrum P-lactamase (ESBL) producers. Piperacillin/tazobactam was the most active agent against isolates of Pseudomonas aeruginosa, followed by meropenem and imipenem. Against Acinetobacter baumannii isolates, meropenem and imipenem were the most active agents. Continued surveillance by the MYSTIC Program appears to be prudent to help focus on effective empiric treatment regimens.
dc.identifier.doi10.1179/joc.2007.19.6.650
dc.identifier.eissn1973-9478
dc.identifier.issn1120-009X
dc.identifier.pubmed18230545
dc.identifier.urihttps://hdl.handle.net/11424/228823
dc.identifier.wosWOS:000252617000005
dc.language.isoeng
dc.publisherTAYLOR & FRANCIS LTD
dc.relation.ispartofJOURNAL OF CHEMOTHERAPY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectantimicrobial resistance
dc.subjectnosocomial infections
dc.subjectsusceptibility surveillance
dc.subjectINTENSIVE-CARE UNITS
dc.subjectGRAM-NEGATIVE BACTERIA
dc.subjectANTIMICROBIAL RESISTANCE
dc.subjectANTIBIOTIC-RESISTANCE
dc.subjectCDC DEFINITIONS
dc.subjectBETA-LACTAMASES
dc.subject8 HOSPITALS
dc.subjectSURVEILLANCE
dc.subjectINFECTIONS
dc.subjectPREVALENCE
dc.titleSusceptibility of bacterial isolates from Turkey - A report from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program
dc.typearticle
dspace.entity.typePublication
local.avesis.idea6b94a8-496d-4b82-ac40-2f0d6a6eb78a
local.import.packageSS17
local.indexed.atWOS
local.indexed.atSCOPUS
local.journal.numberofpages8
oaire.citation.endPage657
oaire.citation.issue6
oaire.citation.startPage650
oaire.citation.titleJOURNAL OF CHEMOTHERAPY
oaire.citation.volume19
relation.isAuthorOfPublication27f6afa3-0e46-45c9-a302-a6493c69bffb
relation.isAuthorOfPublication.latestForDiscovery27f6afa3-0e46-45c9-a302-a6493c69bffb

Files

Collections

Research Outputs